Antiepileptogenesis and disease modification: Clinical and regulatory issues

Antiepileptogenesis and disease modification: Clinical and regulatory issues

Abstract This is a summary report of clinical and regulatory issues discussed at the 2018 NINDS workshop, entitled “Accelerating Therapies for Antiepileptogenesis and Disease Modification.” The intent of the workshop was to optimize and accelerate development of therapies for antiepileptogenesis (AE...

Full description

Bibliographic Details
Main Authors: Jacqueline A. French, Martina Bebin, Marc A. Dichter, Jerome Engel Jr., Adam L. Hartman, Sergiusz Jóźwiak, Pavel Klein, James McNamara Sr., Roy Twyman, Paul Vespa
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Epilepsia Open
Subjects:
antiepileptogenesis
clinical trials
disease modification
Online Access:https://doi.org/10.1002/epi4.12526

Internet

https://doi.org/10.1002/epi4.12526

Similar Items